Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meta-analysis for bioequivalence review

S C Chow1, J Liu

  • 1Biostatistics and Data Management, Bristol-Myers Squibb Company, Plainsboro, New Jersey 08535, USA.

Journal of Biopharmaceutical Statistics
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fatigue reduction by sequential stimulation of multiple motor points in a muscle.

Clinical orthopaedics and related research·1995
Same author

Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection.

Fertility and sterility·1995
Same author

Fluidity of the lipid domain of cell wall from Mycobacterium chelonae.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same author

Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice.

The Journal of pharmacology and experimental therapeutics·1995
Same author

Denaturant unfolding of the ferric enterobactin receptor and ligand-induced stabilization studied by site-directed spin labeling.

Biochemistry·1995
Same author

Identification of an essential cysteinyl residue in the ArsC arsenate reductase of plasmid R773.

Biochemistry·1995
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Ensuring drug interchangeability between generic drugs is crucial for patient safety. A new meta-analysis assesses bioequivalence among generics, offering a tool to monitor performance and improve variability estimates.

Area of Science:

  • Pharmaceutical Sciences
  • Pharmacokinetics
  • Regulatory Science

Background:

  • Current Food and Drug Administration (FDA) regulations permit switching from brand-name drugs to generics if bioequivalent.
  • However, regulations do not explicitly allow switching between different generic versions, even if bioequivalent to the brand-name drug.
  • This lack of clear guidance raises safety concerns regarding drug interchangeability among generic copies.

Purpose of the Study:

  • To address the safety concerns of drug interchangeability among generic drug copies.
  • To propose and perform a meta-analysis for an overview of bioequivalence among generic drugs.
  • To provide a tool for monitoring the performance of approved generic drug copies.

Main Methods:

  • Conducting a meta-analysis to synthesize existing bioequivalence data.

Related Experiment Videos

  • Assessing the bioequivalence among multiple generic copies of a brand-name drug.
  • Estimating inter- and intrasubject variabilities of drug products.

    • Main Results:

    • The meta-analysis provides an overview of bioequivalence across generic drug products.
    • It offers a method to monitor the performance of generic drug approvals.
    • The study yields more accurate estimates of inter- and intrasubject variabilities.

    Conclusions:

    • A meta-analysis of bioequivalence is a valuable tool for assessing drug interchangeability.
    • This approach can enhance the safety monitoring of generic drugs post-approval.
    • Improved variability estimates contribute to a better understanding of drug product performance.